Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 1
1975 2
1986 1
1989 1
1991 1
1992 2
1993 2
1994 2
1995 2
1998 4
1999 7
2000 7
2001 8
2002 8
2003 11
2004 2
2005 10
2006 10
2007 9
2008 11
2009 9
2010 8
2011 8
2012 7
2013 11
2014 16
2015 12
2016 10
2017 10
2018 8
2019 5
2020 9
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

205 results
Results by year
Filters applied: . Clear all
Page 1
Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines.
Mir R, Kelly SM, Xiao Y, Moore A, Clark CH, Clementel E, Corning C, Ebert M, Hoskin P, Hurkmans CW, Ishikura S, Kristensen I, Kry SF, Lehmann J, Michalski JM, Monti AF, Nakamura M, Thompson K, Yang H, Zubizarreta E, Andratschke N, Miles E. Mir R, et al. Among authors: ishikura s. Radiother Oncol. 2020 Sep;150:30-39. doi: 10.1016/j.radonc.2020.05.038. Epub 2020 Jun 3. Radiother Oncol. 2020. PMID: 32504762 Free article.
Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y, Ishizawa K, Maseki N, Itoh K, Usui N, Wasada I, Kinoshita T, Ohshima K, Matsuno Y, Terauchi T, Nawano S, Ishikura S, Kagami Y, Hotta T, Oshimi K. Yamaguchi M, et al. Among authors: ishikura s. J Clin Oncol. 2009 Nov 20;27(33):5594-600. doi: 10.1200/JCO.2009.23.8295. Epub 2009 Oct 5. J Clin Oncol. 2009. PMID: 19805668 Clinical Trial.
Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301).
Atagi S, Kawahara M, Yokoyama A, Okamoto H, Yamamoto N, Ohe Y, Sawa T, Ishikura S, Shibata T, Fukuda H, Saijo N, Tamura T; Japan Clinical Oncology Group Lung Cancer Study Group. Atagi S, et al. Among authors: ishikura s. Lancet Oncol. 2012 Jul;13(7):671-8. doi: 10.1016/S1470-2045(12)70139-0. Epub 2012 May 22. Lancet Oncol. 2012. PMID: 22622008 Clinical Trial.
Mutant KRAS Promotes NKG2D+ T Cell Infiltration and CD155 Dependent Immune Evasion.
Nishi K, Ishikura S, Umebayashi M, Morisaki T, Inozume T, Kinugasa T, Aoki M, Nimura S, Swain A, Yoshida Y, Hasegawa S, Nabeshima K, Sakata T, Shirasawa S, Tsunoda T. Nishi K, et al. Among authors: ishikura s. Anticancer Res. 2020 Aug;40(8):4663-4674. doi: 10.21873/anticanres.14465. Anticancer Res. 2020. PMID: 32727790
Prognostic Value of Epithelial Cell Adhesion Molecules in T1-2N0M0 Glottic Cancer.
Murakami N, Mori T, Machida R, Kodaira T, Ito Y, Shikama N, Konishi K, Matsumoto Y, Murakami Y, Nakamura N, Yamashita H, Yorozu A, Yoshimura M, Inoue K, Nozaki M, Ishikura S, Itami J, Nishimura Y, Kagami Y. Murakami N, et al. Among authors: ishikura s. Laryngoscope. 2021 Jul;131(7):1522-1527. doi: 10.1002/lary.29348. Epub 2020 Dec 28. Laryngoscope. 2021. PMID: 33369763 Clinical Trial.
205 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page